Skip to search formSkip to main contentSkip to account menu

F8, EX4-10DEL

National Institutes of Health

Related topics

Related topics

1 relation
Hemophilia A

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Preparation and Evaluation of a 4-Branched Polyethylene Glycol Derivative Modified with Exendin-4 and Stearylamine for Extended Hypoglycemic Action
− Albumin-modification has been viewed as one of the most effective ways of extending the short in vivo lifetimes of peptide… 
2010
2010
Potential of Site-specific PEGylated Exendin-4 Modified with a High-molecular Weight Trimeric Polyethylene Glycol for Effective Type 2 Anti-diabetic Therapy
SUMMARY Exendin-4 (Ex4) is viewed as a potent therapeutic peptide for type 2 diabetics, but its short circulating life (4-6 h… 
2010
2010
Preparation of PEGylated Exendin-4-loaded PLGA Microspheres for Enhanced Stability and Anti-diabetic Activity
SUMMARY Exendin 4 (Ex4, subsequently renamed exenatide) has a potent efficacy for the treatment of type 2 diabetes under the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)